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The structural details of hepatitis C virus (HCV) have been elusive because of the lack of a robust tissue culture system for producing an
adequate amount of virions from infectious sources for in-depth three-dimensional (3D) structural analysis. Using both negative-stain and cryo-
electron microscopy (cryoEM), we show that HCV virions isolated from cell culture have a rather uniform size of 500 Å in diameter and that
recombinantly expressed HCV-like particles (HCV-LPs) have similar morphologic, biophysical and antigenic features in spite of the varying sizes
of the particles. 3D reconstructions were obtained from HCV-LPs with the same size as the HCV virions in the presence and absence of
monoclonal antibodies bound to the E1 glycoprotein. The 3D reconstruction of HCV-LP reveals a multilayered architecture, with smooth outer-
layer densities arranged in a ‘fishbone’ configuration. Reconstruction of the particles in complex with anti-E1 antibodies shows that sites of the E1
epitope are exposed and surround the 5-, 3- and 2-fold axes. The binding pattern of the anti-E1 antibody and the fitting of the structure of the
dengue virus E glycoprotein into our 3D reconstructions further suggest that the HCV-LP E1 and E2 proteins form a tetramer (or dimer of
heterodimers) that corresponds morphologically and functionally to the flavivirus E homodimer. This first 3D structural analysis of HCV particles
offers important insights into the elusive mechanisms of HCV assembly and maturation.
© 2007 Published by Elsevier Inc.Keywords: Assembly; Envelope protein; Nucleocapsid; Neutralizing antibodies; Viral infectionIntroduction
HCV infects more than 170 million people worldwide and
causes persistent infection in more than 70% of infected people
(Liang et al., 2000). It is the world's leading cause of chronic
liver disease and liver cancer. HCV is a member of the
Flaviviridae family but has been classified into its own genus,
Hepacivirus, because of major differences in genomic organiza-
tion and amino acid sequences from viruses in the Flavivirus
genus, such as dengue virus and West Nile virus (collectively⁎ Corresponding author. Fax: +1 301 402 0491.
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doi:10.1016/j.virol.2007.05.038called flaviviruses). HCV has a positive-strand RNA genome of
about 9.5 kb, which encodes a large polyprotein that is processed
to structural and non-structural proteins by the viral and cellular
proteases. The structural proteins of HCV reside at the N-
terminus of the polyprotein, but unlike flaviviruses, HCV
encodes two distinct envelope glycoproteins, E1 and E2, and
notably lacks a structural or functional homolog of the prM/M
protein found in flaviviruses.
It has been difficult to grow HCV in tissue culture, and only
recently were infectious HCV virions grown successfully in cell
culture (Heller et al., 2005; Lindenbach et al., 2005;Wakita et al.,
2005; Zhong et al., 2005). However, none of the existing
systems produce viral particles of adequate quantity and quality
for three-dimensional (3D) structural analysis. Indeed, no direct
structural information about HCV has been available until now
and our understanding of HCV structure has only been gleaned
through extrapolation of data from analyses of structural proteins
Fig. 1. Electron microscopy of HCV virions purified from cell culture. JFH-1
HCV virions were produced in cell culture and purified by iodixanol density
gradient centrifugation as described in Materials and methods. (A) Negative-
stain TEM micrograph shows that the HCV virions have a rather uniform size
distribution. (B) CryoEM images of HCV virions embedded in vitreous ice.
Because there are no staining and drying artifacts, these cryoEM images of the
HCV virions establish their size of ∼500 Å in diameter and show a smooth
surface morphology with a multilayer outer structural organization (see inset)
similar to that of the mature virions of the dengue and West Nile viruses (Kuhn
et al., 2002; Mukhopadhyay et al., 2003).
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and Watowich, 2002). As a result, very little is known about the
structural organization of HCV. This is in stark contrast to other
members of the Flaviviridae family, such as the dengue virus
(Kuhn et al., 2002; Modis et al., 2003, 2004; Pokidysheva et al.,
2006), tick-borne encephalitis virus (Ferlenghi et al., 2001; Rey
et al., 1995) and West Nile virus (Kanai et al., 2006; Mukho-
padhyay et al., 2003), whose structures have been studied
extensively by both cryo-electron microscopy (cryoEM) and
X-ray crystallography.
In this study, we first show that the HCV virions isolated
from cell culture have a rather uniform size distribution with a
predominant diameter of ∼500 Å by cryoEM and negative-
stain electron microscopy. However, these HCV virions were
not appropriate for 3D reconstruction analysis due to their
limited quantity. Using a baculovirus system to express the
structural proteins of HCV, we produced large amounts of
HCV-like particles (HCV-LPs) similar to HCV virions by
biochemical, cryoEM and immunogold electron microscopy
analyses. 3D reconstructions of the HCV-LP and their
complexes bound with anti-E1 antibodies show a structural
organization similar to those of the dengue and West Nile
viruses. Fitting of the atomic model of dengue virus E protein
into our cryoEM maps further reveals some key structural
differences between HCV-LP and the flaviviruses that are
consistent with the unique aspects of the chemical composition
and viral assembly known for HCV.
Results and discussion
Wild-type HCV virion has a predominant size of 500 Å in
diameter
The biochemistry of HCV has been studied extensively
since it was first discovered in 1989, but its morphology and
size remained controversial. We have successfully isolated
some HCV virions from cell culture and obtained electron
microscopy images of purified HCV virions, both by negative-
stain transmission electron microscopy (TEM) (Fig. 1A) and
cryoEM (Fig. 1B). Our images show that the sizes of the HCV
virions purified from cell culture are quite uniform, having a
diameter of about 500 Å as measured from the cryoEM images
(Fig. 1B). In the cryoEM preparation in particular, the HCV
virions were preserved in a frozen hydrated state. Since there is
no size and structure distortion due to staining and drying
artefacts possible in negative-stain TEM, our data directly
establishes that infectious HCV virion particles have a
predominant size of ∼500 Å. Despite this encouraging result,
the quantity and quality of the HCV virions isolated from cell
culture remain limited and insufficient for in-depth 3D
reconstruction. Nonetheless, our EM images clearly demon-
strated that HCV virions isolated from cultured cells have a
rather uniform diameter of around 500 Å and with a smooth or
spikeless outer surface (Fig. 1B). Thus, HCV shares a size and
morphology with other structurally well characterized members
of the Flaviviridae, such as the dengue virus (Kuhn et al., 2002)
and West Nile virus (Mukhopadhyay et al., 2003).Cryo-electron microscopy and biochemical analyses of
HCV-like particles
To overcome the difficulties in obtaining sufficient amount
of materials needed for in-depth biochemical and cryoEM
structural analyses, we took advantage of the previous success
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et al., 2004). HCV-LPs were isolated by iodixanol density
gradient centrifugation from insect cells infected with recombi-
nant baculovirus expressing HCV structural proteins. CryoEM
examination of the fraction containing the highest concentration
of HCV structural proteins revealed spherical particles with
smooth surfaces (Fig. 2A), consistent with the purified wild-
type HCV virions seen in Fig. 1 and the native HCV virions
isolated from HCV infected patients (Prince et al., 1996;
Trestard et al., 1998), although the recombinant HCV-LPs are
more heterogeneous as judged by particle size distribution
(Figs. 2A, B). This heterogeneity might be due to incorporation
of variable units of HCV E1–E2 dimers during assembly of
HCV-LP. Western blot analysis confirmed that the HCV-LPs are
composed of all three HCV structural proteins (E1, E2 and C)
(Fig. 2C). The different molecular weights of the E1 protein
likely result from different extents of glycosylation.
We next examined the HCV structure by labeling the HCV-
LP with monoclonal antibodies against the HCV E1 protein.
CryoEM images of the antibody-labeled HCV-LPs showed veryFig. 2. CryoEM and immunogold TEM of HCV-LPs. (A) Representative area of a typ
structural flexibility and size heterogeneity but many of the particles have a size simila
value was determined to be 1.7 μm underfocus for this image. (B) Distribution profi
1750 particles. (C) Chemical composition of HCV-LP. SDS–PAGE (Coomassie blue s
structural proteins C, E1 and E2 (marked by asterisks). MW, molecular weight standa
anti-E1 antibodies. The defocus value was determined to be 1.9 μm underfocus for th
by arrows) can be seen forming a ring of densities about HCV-LPs. The inset shows
antibody-labeled HCV-LP preparation. The densities attributed to the bound antibod
than in the cryoEM image. (E) Immunogold TEM of anti-E1 antibody decorated HC
shows that gold particles bind (black dots pointed by white arrows) anti-E1-labeledprominent spikes decorating particles of different sizes (arrows
in Fig. 2D). Collectively, these density spikes form a ring
surrounding the underlying smooth particles (Fig. 2D), indicat-
ing binding of the antibody to HCV-LP. Double-antibody
labeling experiments using monoclonal antibodies against E1
and secondary gold-conjugated anti-IgG antibodies confirmed
that the anti-E1 monoclonal antibody binds to HCV-LPs (Fig.
2E). These labeling experiments confirmed that the outer layer
of the HCV-LP contains E1 protein with its epitope exposed on
the outer surface. As expected, prominent particle aggregation
was also observed in the antibody-labeled HCV-LP experiments
as a consequence of antibody cross-linking (Figs. 2D, E).
Previous biochemical studies have suggested that the HCV
E1 and E2 proteins form heterodimers during the assembly
process (Dubuisson, 2000). Other studies using monoclonal
antibodies against E1 and E2 have suggested that the E1–E2
complexes form the outer surfaces of the native HCV particles,
HCV-LPs and infectious pseudotyped HCV particles (Bartosch
et al., 2003; Meyer et al., 2004; Petit et al., 2005; Prince et al.,
1996; Triyatni et al., 2002a, 2002b). Our results provide the firstical cryoEM micrograph of HCV-LPs. The frozen-hydrated HCV-LPs exhibited
r to that of the HCV virions isolated in cell culture as seen in Fig. 1. The defocus
le of HCV-LP diameters in the cryoEM micrographs based on a total number of
taining) andWestern blotting (IB) of HCV-LPs detected the presence of the HCV
rd. (D) Representative cryoEM image of HCV-LPs in complex with monoclonal
is image. Characteristic spikes attributed to bound antibody molecules (indicated
a negative-stain TEM image of an antibody-decorated HCV-LP from the same
ies (indicated by the arrow) in the negative-stain image are more clearly visible
V-LPs confirming anti-E1 labeling of HCV-LPs. The negative-stain TEM image
HCV-LPs when they were probed with gold-conjugated secondary antibodies.
129X. Yu et al. / Virology 367 (2007) 126–134direct evidence corroborating that E1, likely in complex with
E2, indeed form the outer layer of HCV-LP.
3D reconstructions of HCV-LP and antibody-labeled HCV-LP
As demonstrated above, HCV virions isolated from tissue
culture have a rather uniform diameter of 500 Å (Fig. 1).
Negative-stain TEM of native HCV particles from patient
serum has also shown the existence of 500-Å-diameter
particles (Prince et al., 1996). Moreover, native dengue and
West Nile virus particles have a diameter of 500 Å (Kuhn et
al., 2002; Mukhopadhyay et al., 2003). Therefore, despite of
variations in particle sizes in the HCV-LP preparation (Figs.
2A, B), we decided to focus on the predominant 500-Å
particles for in-depth data processing and 3D reconstruction to
facilitate the structural comparison with those of the dengue
and West Nile virus. A 3D model was reconstructed to a
resolution of 30 Å (Fig. 3B). The convergence of our
extensive phase-residue-based refinement and a stable final
3D reconstruction (see details in Materials and methods) is
indicative of the existence of icosahedral symmetry in selected
HCV-LP. The shaded surface representation of this structure
shows a smooth outer shell with surface indentations (Fig.
3B) and characteristic internal membrane structures (Fig. 3C)
reminiscent of the arrangement of E proteins in dengue virus
and other flaviviruses (Ferlenghi et al., 2001; Kuhn et al.,
2002; Mukhopadhyay et al., 2003). Careful interactive
examination of the 3D density distribution of the 3D re-
construction revealed a similar structural organization of 90
structural components organized in a ‘fishbone’ configura-
tion, which has been well established for other members of
the Flaviviridae (Kuhn et al., 2002; Mukhopadhyay et al.,
2003). The similarity between our reconstruction and other
flavivirus structures support the hypothesis that HCV-LP has
icosahedral symmetry. Density slices extracted from the 3D
reconstruction reveal that the HCV-LP has a multilayer
structural organization (Fig. 3C). The outer layer, which we
interpret to be the E1–E2 protein layer, is about 30 Å thick
and has the highest density as expected for densely packed
glycoproteins.
Our interpretation of E1–E2 outer layer is confirmed by 3D
structural analysis of the anti-E1-labeled HCV-LPs. Consistent
with the TEM observations (Figs. 2D, E), the 3D reconstruc-
tion of antibody-labeled HCV-LPs (Fig. 3D) showed extra
densities attached to the outer E1–E2 layer (pink in Fig. 3E).
A density slice extracted from the antibody-labeled HCV-LP
reconstruction (Fig. 3F) revealed a multilayer structural
organization similar to that of the unlabeled HCV-LP
reconstruction (Fig. 3C). Notably, surrounding the putative
E1–E2 shell in this reconstruction is an extra layer of lower
density, which most likely is due to the E1-bound antibody
molecules. Although the values of the antibody-attributed
densities are significantly above background level, they are
lower than the E1/E2 densities (Fig. 3F), indicating a low
occupancy of the available binding sites and/or flexibility of
the bound antibody molecules. Low antibody occupancy and
antibody flexibility can be due to a number of reasons, in-cluding steric hindrance of the binding sites, low affinity of
the antibody and the flexible hinge regions of individual IgG
molecules. Each antibody density is attached to the E1–E2
shell at three regions: around the 5-fold axes, near the
icosahedral 3-fold axes and flanking the 2-fold axes (Fig. 3F).
These sites roughly coincide with the small protrusions seen at
the 5-, 3- and 2-fold axes of the dengue virus reconstruction at
a similar resolution (Kuhn et al., 2002), although such
protrusions were not visible in the HCV-LP reconstruction.
This observation suggests that the HCV E1–E2 heterodimer
may be organized in a way similar to that of the E monomer of
the flaviviruses. In HCV-LP, each E1 molecule closely
interacts with an E2 protein to form an E1–E2 heterodimer.
Two E1–E2 heterodimers further assemble into a tandem
tetramer, which in turn serves as the basic building block of
the smooth outer surface of the HCV particle.
Below the E1–E2 layer are two lower-density layers
separated by a 40- to 45-Å space (Figs. 3C, F), consistent with
the expected thickness of a lipid bilayer. Although the E1–E2
protein densities contact and, in certain regions, extend through
the underlying envelope bilayer, there is a clear delineation
between the E1–E2 density layer and the lipid bilayer. The
distance between the E1–E2 layer and the outer leaflet of the
bilayer membrane is around 30 Å, similar to that of flaviviruses
(Ferlenghi et al., 2001; Kuhn et al., 2002). In addition, the HCV-
LP membrane bilayer appeared to be affected by the overlying
icosahedral E1–E2 protein layer, adopting a slightly polygonal
shape instead of the typical spherical shape expected for a free
lipid vesicle. Similar to observations made in the structural
studies of the dengue virus (Zhang et al., 2003a, 2003b), the
internal densities corresponding to the capsid core appeared to
be asymmetrically organized and were not clearly resolved in
our HCV-LP reconstruction. Unlike flaviviruses (Ferlenghi et
al., 2001; Kuhn et al., 2002), the HCV-LP reconstruction lacks a
discernable intermediate M protein layer between the E1–E2
layer and the lipid bilayer.
HCV model and comparison with flaviviruses
A structural model of the HCV E2 protein has been proposed
using sequence alignment and fold recognition methods based
on the crystal structure of the tick-borne encephalitis virus
(TBEV) soluble E protein (Yagnik et al., 2000). In this model,
the ectodomain (aa 384–661) of HCV E2 protein is analogous to
domains I and II of the TBEV E protein and the HCV E1 protein
presumably represents domain III of the TBEV E protein. Our
reconstruction of HCV-LP and the identification of E1 antibody
binding sites on the outer surface suggest that the outer shell of
the mature HCV virion is composed of dimers of E1–E2
heterodimers in a head-to-tail tandem configuration (Fig. 3).
That is, each HCV E1–E2 heterodimer is analogous to a
monomer of flavivirus E protein, and each dimer of E1–E2
heterodimers in HCV-LP structurally resembles a flavivirus E-
protein homodimer.
Based on the HCV E2 protein model (Yagnik et al., 2000),
genomic comparison of HCVand flaviviruses (Figs. 4A, B) and
our 3D reconstructions of HCV-LP (Figs. 3B, C) and E1
Fig. 3. 3D reconstructions of unlabeled and antibody-labeled 500-Å HCV-LPs. (A) Boxed-out cryoEM images of unlabeled HCV-LPs from the 500-Å size group. (B)
Shaded surface representation of the 3D reconstruction of HCV-LP at 30-Å resolution, viewed along an icosahedral 3-fold axis. Densities in panels B and E are color
coded according to radius (color bar). Left, map displayed at a contour level of one standard deviation above the mean density. Right, the same map displayed at a
slightly higher density contour level (1.1 times the standard deviation above the mean) to reveal the features with more robust density. (C) A 7-Å-thick density slice
extracted from the HCV-LP reconstruction shows multilayer structural organization. The two red arrowheads indicate the lipid bilayer; the blue arrow indicates the
capsid. Unlike the dengue virus, the HCV-LP lacks an intermediate density layer corresponding to the M-protein layer. The outer layer (black arrow) is attributed to the
E1 and E2 proteins. (D) Boxed-out cryoEM images of antibody-labeled HCV-LPs from the same size group. (E) Shaded surface representation of the 3D
reconstruction of antibody-labeled HCV-LP, viewed along an icosahedral 3-fold axis. The putative antibody densities are shown in pink. (F) A density slice extracted
from the 3D reconstruction of antibody-labeled HCV-LP. The lipid bilayer and E1/E2 layer are indicated as in panel C. The extra layer of lower density surrounding the
particle is attributed to the antibodies.
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for the HCV structural organization (Fig. 4C) in which the
E1–E2 tetramer (Fig. 4B) serves as the basic building block of
the outer shell. Ninety copies of this building block are
arranged in a manner similar to that of the flavivirus E-protein
dimers to form an outer shell of 500 Å in diameter (Fig. 4C).The E2 protein of HCV takes the place of domains I and II of
the dengue E protein, while the dengue virus E protein
domain III is replaced by the E1 protein in HCV. The locations
of the E1 protein in the HCV structure model are consistent with
the binding sites of the anti-E1 antibodies in our structural
studies.
Fig. 4. Comparison of the envelope proteins and their structural organization in TBEVand HCV. (A) Genomes of TBEVand HCV, with homologous coding domains
in the envelope proteins indicated by dotted lines (Yagnik et al., 2000). (B) Structural components of the virus' outer shells: TBEV E-protein dimer and HCV E1–E2
tetramer. (C) Construction of the HCVouter shell from the E1–E2 tetramer. For clarity, only a facet of the icosahedral shell is shown, and the 3- and 5-fold symmetry
axes are indicated.
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brane fusionmechanismwith other flaviviruses but may differ in
its receptor binding. The latter is supported by the observation
that the regions of HCVE1 and E2 proteins that are important for
receptor interaction are located in the general vicinity of domain
III of the flavivirus E protein, which has a similar function
(Ferlenghi et al., 2001; Hurrelbrink and McMinn, 2001; Kuhn
et al., 2002; Mandl et al., 2000; Modis et al., 2003). Contrary to
that of flaviviruses, our model of the HCV outer shell
organization implies that the infectivity of HCV depends on
both the E1 and E2 proteins. Indeed, competition studies with
monoclonal antibodies using HCV-LPs and HCV pseudoviruses
have shown that the entry of HCV into host cells involves
multiple receptors that are recognized by E1 and/or E2. The
intricate interactions among E1, E2 and the putative receptor(s)
involved in HCV entry await further structural elucidation.
Fitting of the existing model of the dengue virus E protein
(Kuhn et al., 2002) into our HCV-LP density map by
maximizing the correlation between the cryoEM density and
dengue E model (see Materials and methods) revealed a good
match between the HCV ‘fishbone’ structure and the dengue
virus E dimers (Fig. 5A). The dengue virus E protein dimer
matches well with the density features representing the putative
E1–E2 tetramer of HCV-LP, except in the regions around the
two ends of the E protein dimers where the flavivirus E protein
domain III resides (Fig. 5B). As discussed above, the flavivirus
E protein has an immunoglobulin-like domain III that displays a
small protrusion on the viral surface. The HCV E1 protein,
while structurally replacing this domain III as supported by our
localization of the anti-E1 binding site on the HCV-LP (Fig.
3E), lacks such a protruding region.
HCV is distinct from dengue virus and other flaviviruses, at
least with respect to the mechanisms of virus assembly andmaturation. Notably, the HCV-LP lacks the M protein layer
between the E protein and lipid bilayer. The M protein is
believed to play a key role in the transformation of the
immature structure, which has surface protrusions, to the
mature, smooth-surfaced structure (Allison et al., 2003; Zhang
et al., 2003b). Cleavage of the preM by furin causes the
dissociation of the preM-E heterodimer and the exposure of the
dimerization domain (domain II) of the E protein to form the E
homodimer.
Although the assembly of HCV has not been completely
elucidated, our findings suggest that the assembly of HCV is
generally similar to that of the flaviviruses but with some
distinctive features. The HCV E1–E2 heterodimer, which forms
in the endoplasmic reticulum during or shortly after translation
of the HCV polyprotein, may first assemble into immature viral
particles. The heterodimers would then undergo conformational
changes to expose the E2 dimerization domains to form dimers
of E1–E2 heterodimers leading to the assembly of the outer
shell of the mature HCV particle. Unlike flaviviruses, the
conformational changes of HCV glycoproteins may occur
without proteolytic cleavage, and the E1 and E2 proteins may
interact closely during the assembly process, with both proteins
located on the surface of the mature virion. In contrast, only E
protein is exposed on the outer surface and the mature M protein
is buried between the E protein layer and the lipid bilayer in the
flaviviruses.
In summary, we have obtained the first 3D model of the
HCV particle and obtained direct structural evidence of the
external localization of HCV E1. As the first model of a
hepacivirus, it reveals key differences and similarities in the
structural organization between hepaciviruses and flaviviruses.
Further investigation of this model as well as HCV virions
isolated from cell culture will provide important insights into
Fig. 5. Fitting of the dengue virus E protein model into the HCV-LP
reconstruction. (A) Superposition of the dengue virus E protein model (shown as
ribbons) (Kuhn et al., 2002; Modis et al., 2003) over the 3D map of HCV-LP.
Five-fold, three-fold and two-fold axes are indicated by ‘5’, ‘3’ and ‘2’,
respectively. The arrow indicates the protruding domain III of the dengue virus E
protein. (B) Close-up of the region within the dotted line in A. Only three
neighboring dengue E-protein dimers are shown for clarity.
132 X. Yu et al. / Virology 367 (2007) 126–134the viral assembly and life cycle of HCV. An understanding of
the molecular interactions among HCV structural proteins,
particularly at higher resolution level, may ultimately reveal
novel targets for rational anti-HCV intervention.
Materials and methods
HCV virion purification
JFH-1 HCV virions were produced in cell culture as
described previously (Kato et al., 2007; Wakita et al., 2005).
The culture medium was first cleared of cellular debris with a
0.45-μm filter. The secreted virions were concentrated by
polyethylene glycol 8000 and then subjected to iodixanol
density gradient analysis (Heller et al., 2005; Kato et al., 2007).
The fractions were examined by negative-stain (2% uranyl
acetate) transmission electron microscopy (TEM) and the
virion-containing fraction was pelleted and resuspended in10 mM phosphate-buffered saline (PBS) pH 7.4 for cryoEM
imaging.
HCV-LP purification and antibody labeling
HCV-LPs were purified from insect cells infected by
recombinant baculoviruses expressing HCV structural proteins
(bvHCV.Sp7-) as described (Jeong et al., 2004; Qiao et al.,
2004). For antibody labeling, isolated HCV-LPs were incubated
with purified mouse monoclonal anti-E1 antibody (E1A4) (from
Harry Greenberg, Stanford, CA) at 4 °C for 1 h. The complexes
were then subjected to iodixanol density gradient centrifugation
(20–50% gradient) in a Beckman SW55 rotor at∼230,000 g for
5 h at 4 °C. Fractions were collected, checked for particle
concentration and integrity by negative-stain TEM. Selected
HCV-LP-containing fraction was confirmed byWestern blot and
subsequently resuspended in 10 mM PBS pH 7.4 for cryoEM.
For gold labeling, secondary antibodies conjugated to 10-nm
gold particles (KPL, Gaithersburg, MD) were incubated with
anti-E1 antibody-labeled HCV-LPs overnight. They were then
run through a sucrose gradient to remove unbound secondary
antibodies, stained with 2% uranyl acetate and examined by
TEM.
CryoEM and 3D reconstruction
CryoEM imaging of HCV-LPs and antibody-labeled HCV-
LPs was performed as described previously (Yu et al., 2005;
Zhou et al., 2000). Briefly, a 3-μl aliquot of 1.5 mg/ml unlabeled
or antibody-labeled HCV-LPs was applied to a Quantifoil R 2/1
grid (Quantifoil Micro Tools Gmbh, Jena, Germany), quickly
blotted with filter paper and plunged into liquid nitrogen-cooled
liquid ethane so that the HCV-LPs or their antibody-labeled
complexes were embedded in a thin layer of vitreous ice across
the holes of carbon supporting film. Images were recorded at a
magnification of 40,000× at 100 kV in a JEOL1200 cryo-
electron microscope using an electron dose of ∼10 electrons/
Å2/micrograph.
For 3D reconstruction, selected micrographs (60 focal pairs
for HCV-LP, 67 focal pairs for antibody-labeled HCV-LP) in the
proper defocus range and without apparent specimen drift and
charging were digitized on a Zeiss SCAI microdensitometer (Z/I
Imaging, Huntsville, AL) using a step size equivalent to 7 Å/
pixel on the specimen. Data processing and visualization were
carried out on Dell Workstations with Windows XP using
Fourier common-lines-based procedures implemented in the
IMIRS software package, as previously described (Liang et al.,
2002). The defocus values of the micrographs were determined
using the incoherently averaged Fourier transforms of particle
images. The underfocus values of the micrographs of HCV-LP
and antibody-labeled HCV-LP range from 1.5 to 2.8 μm and 1.4
to 2.9 μm, respectively.
Size distribution analysis was carried out by an automatic
boxing program (winBoxer, Blake Young and Z. H. Zhou,
unpublished) using circles with different diameters as templates.
We then manually selected 990 HCV-LPs and 432 antibody-
labeled HCV-LPs from the 500-Å group for in-depth iterative
133X. Yu et al. / Virology 367 (2007) 126–134refinement and 3D reconstructions. Most of those particles were
eliminated by setting gradually more stringent cut-off value of
phase-residues until no improvements of 3D reconstruction were
observed as more particles are eliminated. The final 3D recon-
structions were generated to 30 Å by merging 110 HCV-LPs or
87 antibody-labeled HCV-LPs. The 3D visualization was per-
formed using Iris Explorer (NAG, Downers Grove, IL) with
custom-designed modules and UCSF Chimera (Pettersen et al.,
2004). The PDB file with the atomic coordinates of the dengue E
protein was downloaded directly from the Protein Data Bank for
fitting into our cryoEM structures as described previously (Zhou
et al., 2001). Fitting of the atomic model into the cryoEMdensity
map was achieved by using the ‘Fit Model in Map’ functionality
in the UCSF Chimera package, which maximizes the cross
correlation between the cryoEM density map and the dengue E
protein model.
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